Endocrine System Drug Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL ENDOCRINE SYSTEM DRUG INDUSTRY

2.1 Summary about Endocrine System Drug Industry

2.2 Endocrine System Drug Market Trends

2.2.1 Endocrine System Drug Production & Consumption Trends

2.2.2 Endocrine System Drug Demand Structure Trends

2.3 Endocrine System Drug Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Diabetes Drug

4.2.2 Human Growth Hormones

4.2.3 Thyroid Hormone Disorder Drugs

4.2.4 Others

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Hospital

4.3.2 Clinic

4.3.3 Medical Center

4.3.4 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Diabetes Drug

5.2.2 Human Growth Hormones

5.2.3 Thyroid Hormone Disorder Drugs

5.2.4 Others

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Hospital

5.3.2 Clinic

5.3.3 Medical Center

5.3.4 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Diabetes Drug

6.2.2 Human Growth Hormones

6.2.3 Thyroid Hormone Disorder Drugs

6.2.4 Others

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Hospital

6.3.2 Clinic

6.3.3 Medical Center

6.3.4 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Diabetes Drug

7.2.2 Human Growth Hormones

7.2.3 Thyroid Hormone Disorder Drugs

7.2.4 Others

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Hospital

7.3.2 Clinic

7.3.3 Medical Center

7.3.4 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Diabetes Drug

8.2.2 Human Growth Hormones

8.2.3 Thyroid Hormone Disorder Drugs

8.2.4 Others

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Hospital

8.3.2 Clinic

8.3.3 Medical Center

8.3.4 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Diabetes Drug

9.2.2 Human Growth Hormones

9.2.3 Thyroid Hormone Disorder Drugs

9.2.4 Others

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Hospital

9.3.2 Clinic

9.3.3 Medical Center

9.3.4 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Novo Nordisk

10.1.2 Sanofi

10.1.3 Merck

10.1.4 Eli Lilly

10.1.5 AstraZeneca

10.1.6 AbbVie

10.2 Endocrine System Drug Sales Date of Major Players (2017-2020e)

10.2.1 Novo Nordisk

10.2.2 Sanofi

10.2.3 Merck

10.2.4 Eli Lilly

10.2.5 AstraZeneca

10.2.6 AbbVie

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

1.Table Endocrine System Drug Product Type Overview

2.Table Endocrine System Drug Product Type Market Share List

3.Table Endocrine System Drug Product Type of Major Players

4.Table Brief Introduction of Novo Nordisk

5.Table Brief Introduction of Sanofi

6.Table Brief Introduction of Merck

7.Table Brief Introduction of Eli Lilly

8.Table Brief Introduction of AstraZeneca

9.Table Brief Introduction of AbbVie

10.Table Products & Services of Novo Nordisk

11.Table Products & Services of Sanofi

12.Table Products & Services of Merck

13.Table Products & Services of Eli Lilly

14.Table Products & Services of AstraZeneca

15.Table Products & Services of AbbVie

16.Table Market Distribution of Major Players

17.Table Global Major Players Sales Revenue (Million USD) 2017-2020e

18.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

19.Table Global Endocrine System Drug Market Forecast (Million USD) by Region 2021f-2026f

20.Table Global Endocrine System Drug Market Forecast (Million USD) Share by Region 2021f-2026f

21.Table Global Endocrine System Drug Market Forecast (Million USD) by Demand 2021f-2026f

22.Table Global Endocrine System Drug Market Forecast (Million USD) Share by Demand 2021f-2026f